DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Skybiotech Healthcare Limited (SKYBIOTECH) share price today?

Skybiotech Healthcare Limited (SKYBIOTECH) is trading at ₹142.75 on the BSE, up 4.96% on the day. Source: DocStoX.

What is the PE ratio of Skybiotech Healthcare Limited?

Skybiotech Healthcare Limited has a price-to-earnings (PE) ratio of 13.4 in the Consumer Discretionary sector.

What is the market capitalisation of Skybiotech Healthcare Limited?

Skybiotech Healthcare Limited has a market capitalisation of approximately ₹27 crore.

Skybiotech Healthcare Limited

SKYBIOTECH·BSE·Consumer Discretionary

₹142.75▲ +6.75 (+4.96%)

Consumer Discretionary · Textiles & Apparels

A steady, established business

Day₹135.00

₹142.80

52W₹116

₹23722%

Open

₹142.70

High

₹142.80

Low

₹135.00

Prev Close

₹136.00

Volume

2.2K

VWAP

₹138.55

Snapshot

Key fundamentals

Market Cap

₹27 Cr

P/E Ratio

13.38Cheap

P/B Ratio

3.26

EPS

₹10.67

Book Value

₹41.75

ROE

-22.48%Weak

ROCE

-13.76%Weak

Dividend Yield

0.00%

Debt / Equity

1.05Elevated

Face Value

₹10.00

52W High

₹237.30

52W Low

₹116.45

Sector

Consumer Discretionary

Industry

Textiles & Apparels

Avoid

None moatHigh uncertainty

Fair value estimate

₹44

▼ 68.9%downside

Trading at ₹143 — 69% above our estimate

BearFair valueBull

₹24₹44₹118

/100

Business quality — Watch the fundamentals

Growth 50Profitability 0Efficiency 0Valuation 70

Plain English

Our view

A steady, established business
Reasonably priced at 13× earnings
Weak returns on equity (-22%)

Strengths

Reasonably priced at 13× earnings
Promoters hold a controlling stake

Risks

Weak returns on equity (-22%)

How we got there

Fair value methods

Residual income

-22% ROE fading to 14% over ~3 yrs, on ₹42 book

₹24

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹118

Analyst target

No analyst coverage

—

Blended fair value₹44

What the numbers say

Investment thesis

Bull case

Reasonably priced at 13× earnings
Promoters hold a controlling stake

Bear case

Weak returns on equity (-22%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

13.4Cheap

Below 15× is value territory; above 35× prices in strong growth

ROE

-22.5%Weak

Above 15% is considered healthy for Indian equities

ROCE

-13.8%Weak

Above 18% means capital is working hard

Debt/Eq

1.05Elevated

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹27 Cr

P/B

3.26

EPS

₹10.67

Div Yield

—

What changed

Recent changes

No notable changes to report.

What matters

News impact

Overview

Valuation

Attractive

P/E 13.4×

Growth

N/A

No history

Profitability

Loss-making

-22.5% ROE

Financial health

Leveraged

D/E 1.05

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover₹3.05L Cr

Trades26

VWAP₹138.55

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

No growth history

Not enough annual history to compute CAGR.

Profile

Cons

Stock is trading at 3.26 times its book value
Company has low interest coverage ratio.
Company might be capitalizing the interest cost
Debtor days have increased from 39.5 to 57.1 days.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Ownership was broadly stable versus the previous quarter. The QoQ column shows each group's change versus the prior quarter.

63%

Promoter

Promoters

63.5%0.00

Public

34.6%-0.23

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

1.9%

Total shareholders

610-10 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter63.48%

Public34.65%

Others1.87%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 1983, Skybiotech Healthcare Ltd is in the business of Textile and Pharmaceuticals[1]